Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the self-administered drug formulation in lupus patients with a positive phase ... Healio: TULIP-SC: Subcutaneous anifrolumab bests placebo in multiple lupus outcomes at 52 weeks TULIP-SC: Subcutaneous anifrolumab bests placebo in multiple lupus outcomes at 52 weeks Lupus Foundation of America: How do I know if I have subacute cutaneous lupus or discoid lupus? What is the difference?

Context Explanation

Both subacute cutaneous lupus and discoid lupus are a form of lupus skin disease, though they have some distinct differences. Subacute cutaneous lupus may show up as ring-shaped red, scaly lesions. How do I know if I have subacute cutaneous lupus or discoid lupus? What is the difference?

Insight Material

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a new subcutaneous route of administration for Saphnelo (anifrolumab), used as an add-on ...